申请人:Thompson, III Lorin A.
公开号:US08604024B2
公开(公告)日:2013-12-10
Compounds of formula (I), including pharmaceutically acceptable salts thereof, are set forth herein:
wherein X is selected from the group of CH2, O, and NR2;
m=0 or 1;
R1 at each instance is selected from the group of halogen, hydroxy, amino, C1-4alkylamino, C1-4dialkylamino, haloC1-4 alkyl, CN, C1-C6 alkyl or cycloalkyl, C1-C6 alkoxy, and C2-C4 alkynyl;
L is a bond, —NHCO—, —NH—, or L and Z together can be absent;
Z is a C6-C10-aryl group or a 5-10 membered heterocyclic group which can be further substituted with from 0-3 substituents selected from the group of halogen, haloC1-4 alkoxy, 4-methoxyphenyl, hydroxy, amino, C1-4alkylamino, C1-4dialkylamino, haloC1-4 alkyl, CN, C1-C6 alkyl or cycloalkyl, C1-C6 alkoxy, and C2-C4 alkynyl;
R2 is selected from the group of hydrogen, benzyl, C1-C6 alkyl or cycloalkyl, C1-C6 alkoxy, acetyl, and methanesulfonyl;
and R3, R4 and R5 are independently selected from hydrogen or C1-4alkyl.
以下列出了化学式(I)的化合物,包括其药学上可接受的盐:
其中,X选自CH2、O和NR2的群组;m=0或1;每个R1都选自卤素、羟基、氨基、C1-4烷基氨基、C1-4二烷基氨基、卤代的C1-4烷基、CN、C1-C6烷基或环烷基、C1-C6烷氧基和C2-C4炔基的群组;L是一个键、-NHCO-、-NH-或L和Z一起可以不存在;Z是一个C6-C10芳基或一个5-10成员杂环基,可以进一步用来自卤素、卤代的C1-4烷氧基、4-甲氧基苯基、羟基、氨基、C1-4烷基氨基、C1-4二烷基氨基、卤代的C1-4烷基、CN、C1-C6烷基或环烷基、C1-C6烷氧基和C2-C4炔基的0-3个取代基进行取代;R2选自氢、苄基、C1-C6烷基或环烷基、C1-C6烷氧基、乙酰基和甲磺酰基的群组;R3、R4和R5独立地选自氢或C1-4烷基。